The following article (hyperlinked), which I wrote for The Seoul Times, refers to a proposal by Professor Norman Ende, M.D. for establishing antibiotics and cord blood as a national ‘first line’ of radiation defense. I’ve presented the details of this plan in the links that follow.
The Seoul Times, 1/22/11 by J. Perry Kelly
Two weeks ago, a former U.S. Air Force Surgeon General wanted to share a plan for treating mass radiation casualties with the South Korean military. A U.S. government liaison tried to dissuade him on the irrelevant grounds that many casualties in a nuclear blast suffer from its direct effects, burns and physical trauma, rather than hematopoietic syndrome—the loss of immune functions due to bone marrow damage through exposure to radiation.
In a letter published online in the January 2011 issue of International Journal of Radiation Biology, cord blood medical pioneer Dr. Norman Ende writes, “The current availability of advanced antibiotics and human cord blood…coupled with readily available intravenous fluids, would, in our opinion, save 80 to 90% of those who survive the first 72 hours following an accidental or intentional nuclear detonation.”
The eighty-six year old Ende first established cord blood’s medical potentials for cancer in the mid-sixties and early seventies. He supports his present claim by placing research that expands cord blood potentials for rescuing bone marrow in context with pathological reports from Hiroshima and Nagasaki. Regarding these reports, Ende says, “Most of the deaths that occurred after two weeks were the direct and indirect effect of a compromised immune system.”
For reasons presented below (See “Radiation Critical Care” and “Manhattan Nuclear Scenario“), the general’s plan—a plan based on Ende’s research—may offer the only practical hope for mass casualties who suffer radiation sickness from a nuclear attack.
South Korea might feel betrayed its long-standing ally didn’t share this medical strategy sooner—like last February when North Korea threatened the South with nuclear war. Instead, if not for the outrage and persistence of a retired Air Force general, the South Korean government might never have learned of this critical solution to a medical nightmare.
Whether South Korea plans to enact Ende’s strategy remains unclear.
U.S. law stipulates cord blood should be used “in concert with Federal programs for response to terrorist or military weapons that can damage bone marrow.” Nonetheless, despite Ende offering his plan to Washington and the City of New York in 2006, and in spite of its presentation to the White House National Security Staff in February of 2010, America remains without a viable strategy for treating mass radiation casualties. The Peoples Republic of China, however, thought Ende’s proposal made perfect sense.
In 2002, Vice President Hu Jintao of the People’s Republic (the current Chairman of the Communist Party and President of the People’s Republic) met in New York with Ende’s associate, a Chinese national named Dr. R. Chen. Hu ordered his aides to take scrupulous notes concerning every aspect of Ende’s proposal.
Since the U.S. government chooses to allow Americans to remain without hope if they’re exposed to radiation, perhaps the peoples of the Middle East, India, Pakistan, South Korea, and South Korea’s neighbors in China and Japan—billions of humans who face the specter of nuclear threats—should not feel offended that U.S. folly endangers their lives…a reality Ende reveals in his blueprint for treating ten-thousand victims of a nuclear attack in Manhattan:
“At this point,” he said in the 2006 report, “the establishment of a logistical plan could potentially save thousands. Currently, no money is needed, simply a plan for basic communication, logistics and use of existing facilities.”